Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachna Aneja

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecules (Basel, Switzerland)|August 21, 2013
Click chemistry in peptide-based drug designHuiyuan Li, Rachna Aneja, Irwin Chaiken
Biochemistry|August 8, 2013
Multiple exosites distributed across the three domains of streptokinase co-operate to generate high catalytic rates in the streptokinase-plasmin activator complexRachna Aneja, Manish Datt, Suman Yadav, et al.
The Journal of Biological Chemistry|October 6, 2009
Identification of a new exosite involved in catalytic turnover by the streptokinase-plasmin activator complex during human plasminogen activationRachna Aneja, Manish Datt, Balwinder Singh, et al.
The Journal of Biological Chemistry|December 21, 2010
Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinaseSuman Yadav, Rachna Aneja, Prakash Kumar, et al.
Journal of Medicinal Chemistry|September 3, 2015
Macrocyclic Envelope Glycoprotein Antagonists that Irreversibly Inactivate HIV-1 before Host Cell EncounterAdel A Rashad, Ramalingam Venkat Kalyana Sundaram, Rachna Aneja, et al.
Clinical Nutrition ESPEN|January 22, 2022
Phase I single center trial of ketogenic diet for adults with traumatic brain injuryNiraj Arora, N Scott Litofsky, Mojgan Golzy, et al.
Organic & Biomolecular Chemistry|August 4, 2017
Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ringAdel A Rashad, Kriti Acharya, Ann Haftl, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 28, 2019
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomesRachna Aneja, Antonella Grigoletto, Aakansha Nangarlia, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Differentiation SELEX approach identifies RNA aptamers with different specificities for HIV-1 capsid assembly formsPaige R Gruenke, Miles D Mayer, Rachna Aneja, et al.
Journal of Medicinal Chemistry|April 11, 2015
Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120Rachna Aneja, Adel A Rashad, Huiyuan Li, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|August 21, 2013
Click chemistry in peptide-based drug designHuiyuan Li, Rachna Aneja, Irwin Chaiken
Biochemistry|August 8, 2013
Multiple exosites distributed across the three domains of streptokinase co-operate to generate high catalytic rates in the streptokinase-plasmin activator complexRachna Aneja, Manish Datt, Suman Yadav, et al.
The Journal of Biological Chemistry|October 6, 2009
Identification of a new exosite involved in catalytic turnover by the streptokinase-plasmin activator complex during human plasminogen activationRachna Aneja, Manish Datt, Balwinder Singh, et al.
The Journal of Biological Chemistry|December 21, 2010
Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinaseSuman Yadav, Rachna Aneja, Prakash Kumar, et al.
Journal of Medicinal Chemistry|September 3, 2015
Macrocyclic Envelope Glycoprotein Antagonists that Irreversibly Inactivate HIV-1 before Host Cell EncounterAdel A Rashad, Ramalingam Venkat Kalyana Sundaram, Rachna Aneja, et al.
Clinical Nutrition ESPEN|January 22, 2022
Phase I single center trial of ketogenic diet for adults with traumatic brain injuryNiraj Arora, N Scott Litofsky, Mojgan Golzy, et al.
Organic & Biomolecular Chemistry|August 4, 2017
Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ringAdel A Rashad, Kriti Acharya, Ann Haftl, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 28, 2019
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomesRachna Aneja, Antonella Grigoletto, Aakansha Nangarlia, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Differentiation SELEX approach identifies RNA aptamers with different specificities for HIV-1 capsid assembly formsPaige R Gruenke, Miles D Mayer, Rachna Aneja, et al.
Journal of Medicinal Chemistry|April 11, 2015
Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120Rachna Aneja, Adel A Rashad, Huiyuan Li, et al.
Pageof 2